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Abstract
Objective—Obesity is a risk factor for congenital heart defects (CHD), but whether risk is
independent of abnormal glucose metabolism is unknown. Data on whether overweight status
increases risk is also conflicting.
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Research Design and Methods—We included 121815 deliveries from a cohort study, the
Consortium on Safe Labor, after excluding women with pregestational diabetes as recorded in the
electronic medical record. CHD were identified via medical record discharge summaries. Adjusted
odds ratios (OR) for any CHD were calculated for prepregnancy body mass index (BMI)
categories of overweight (25 to <30 kg/m2), obese (30 to <40 kg/m2), and morbidly obese (≥40
kg/m2) compared to normal weight (18.5 to <25 kg/m2) women, and for specific CHD with obese
groups combined (≥30 kg/m2). A sub-analysis adjusting for oral glucose tolerance test (OGTT)
results where available was performed as a proxy for potential abnormal glucose metabolism
present at the time of organogenesis.
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Results—There were 1388 (1%) infants with CHD. Overweight (OR=1.15 95% CI: 1.01–1.32),
obese (OR=1.26 95% CI: 1.09, 1.44), and morbidly obese (OR=1.34 95% CI: 1.02–1.76) women
had greater odds of having a neonate with CHD than normal weight women (P< 0.001 for trend).
Obese women (BMI ≥30 kg/m2) had higher odds of having an infant with conotruncal defects
(OR=1.34 95%CI: 1.04–1.72), atrial septal defects (OR =1.22 95% CI: 1.04–1.43), and ventricular
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septal defects (OR=1.38 95% CI: 1.06–1.79). Being obese remained a significant predictor of
CHD risk after adjusting for OGTT.
Conclusion—Increasing maternal weight class was associated with increased risk for CHD. In
obese women, abnormal glucose metabolism did not completely explain the increased risk for
CHD; the possibility that other obesity-related factors are teratogenic requires further
investigation.
Keywords
Prepregnancy BMI; Obesity; Congenital Heart Defects

Background and Significance
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The majority of studies have found an association between maternal obesity and congenital
heart defects (CHD).1–9 It is not clear whether the association between obesity and CHD can
be explained by maternal diabetes, a known teratogen, because previous studies have not
had detailed information on maternal glucose status. It is also not known whether mild
elevations in maternal glucose could be responsible for the excess in CHD seen in offspring
of obese women. This hypothesis is reasonable given that other adverse birth outcomes such
as macrosomia have a linear association with maternal blood glucose even below the level
that meets the criteria for a diagnosis of gestational diabetes.10, 11 Thus, data are needed to
clarify whether obesity is in fact a risk factor for CHD independent of blood glucose level.
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The literature is also conflicting regarding whether overweight status increases CHD
risk.2, 3, 5, 6 Moreover, most studies have had insufficient numbers of subjects to investigate
the relationship between obesity or overweight and classes of cardiac defects or individual
defects.7
Using data from the Consortium on Safe Labor (CSL), a large United States cohort study,
we investigated the association between prepregnancy body mass index (BMI) and odds of
congenital cardiac defects overall and for specific defects where enough cases were
available. In a subset of women with diabetes-screening data available, we also investigated
the odds of CHD by weight status after adjusting for blood glucose levels.

Methods
Study Design and Methods
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The Consortium on Safe Labor (CSL) was an observational study of medical records with
prospectively entered data conducted by the Eunice Kennedy Shriver National Institute of
Child Health and Human Development at 12 clinical centers (19 hospitals). It was designed
to study contemporary obstetric management as well as maternal, obstetric, and neonatal
outcomes given the changing maternal socio-demographics in regard to increased maternal
age and body mass index (BMI).12, 13 Information on maternal demographic characteristics
(including height, prepregnancy weight, race, educational attainment, insurance status, and
age); medical, reproductive, and prenatal history (including pregestational diabetes status,
parity, and smoking and alcohol use during pregnancy); pregnancy complications including
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development of gestational diabetes mellitus (GDM); and labor, delivery, postpartum, and
newborn outcomes was abstracted from electronic medical records. Information from the
neonatal intensive care units (NICU) was linked to the newborn records. Maternal and
newborn discharge summaries, in International Classification of Diseases-9 (ICD-9) codes,
were linked to each delivery. CHD status for each infant was obtained via discharge record
ICD-9 codes (Appendix A). Infants with isolated and multiple defects were examined
together. Congenital heart defects were categorized as previously described14, and infants
with more than one cardiac defect were categorized in a hierarchical fashion. Infants who
had more than one cardiac defect were analyzed in each group. CHD cases related to
aneuploidy were excluded.
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The CSL study included 208695 women with 228562 deliveries at 23 weeks of gestation or
later, occurring between 2002 and 2008. Women were excluded if they had multiple
gestations (n=3234), were missing pre-pregnancy BMI information (n=76952), or had
pregestational diabetes (n=18786). One site was excluded because it did not report
pregestational diabetes status (n=7877). Women with missing BMI data had a higher
percentage of neonates with CHD, compared to those with known BMI (1.7% versus 1.1%,
p<0.01 by Chi-squared test). The critical period for most heart defects is 14 to 60 days after
conception.2 Because gestational diabetes is usually not diagnosed until later in pregnancy
around 24 – 28 weeks of gestation,15 we included women with gestational diabetes in the
main analysis. However, since some women diagnosed as having gestational diabetes may
have had undiagnosed diabetes during organogenesis, we performed a sensitivity analysis
excluding all women with pregnancies complicated by gestational diabetes.
Statistical Analysis

Author Manuscript
Author Manuscript

Potential confounders were identified by comparing the distribution of baseline
characteristics among women with infants with and without any type of CHD. For
categorical factors, chi-squared tests were used. For continuous factors, t-tests were used.
All factors with P≤0.05 were then included in a multivariable model. We adjusted for site to
account for the potential differences in diagnoses by the different institutions. We adjusted
for race and age because the Baltimore Washington Infant Heart Study reported race and age
differences for some defects.16 The multivariable model related the odds ratio of having an
infant with a CHD to categories of BMI (underweight: BMI < 18.5 kg/m2; normal weight:
BMI 18.5 to < 25 kg/m2; overweight: BMI 25 to < 30 kg/m2; obese: BMI 30 to < 40 kg/m2;
morbidly obese: BMI ≥ 40 kg/m2), while adjusting for each of the selected confounders, site,
age, race, insurance, and maternal smoking. Women with multiple deliveries were accounted
for in the model through a common random effect using PROC GENMOD of SAS.17 All
reported tests were two-sided with P≤0.05 taken as statistically significant. SAS (SAS
Institute Inc, Cary, NC) version 9.1 was used for the statistical analysis.
Additional models combined all obese subjects into a single group: BMI ≥ 30. Further
models examined specific types of CHD where n >50, decided a priori. For each model a
test for trend was obtained by replacing the categorical BMI with a continuous BMI term.
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Oral glucose tolerance test (OGTT) results were available at one site (n=5131). We
performed a sub-analysis additionally adjusting for continuous OGTT results as a proxy for
potential abnormal glucose metabolism present at the time of organogenesis.

Results

Author Manuscript

After the exclusions noted above, the study sample consisted of 121815 singleton births
from 114819 women. There were 1388 cases of any type of CHD, 1.1% of the study
population. Table 1 presents maternal characteristics. Mean maternal BMI was higher for
women who had a neonate with any type of CHD compared to women whose neonates did
not have CHD (26.3 kg/m2 versus 25.5 kg/m2, respectively, P<0.001). Compared to women
who did not give birth to an infant with CHD, women who gave birth to infants with CHD
were more likely to be overweight (25.4% compared to 23.7%) or obese (BMI ≥ 30 kg/m2)
(22.6% versus 19.6%). Women whose infants had CHD were also less likely to be privately
insured, and more likely to smoke during pregnancy and be diagnosed with gestational
diabetes mellitus (GDM).
Increasing prepregancy BMI was associated with an increased odds for having an infant
with CHD: 1.18-fold for overweight, 1.25-fold for obese, and 1.36-fold for morbidly obese
women (P<0.001 for trend) (Table 2). These results remained significant but were slightly
attenuated after adjusting for site, age, race, insurance, and maternal smoking. There was no
association of CHD with underweight.

Author Manuscript

GDM complicated 2.2% of pregnancies of normal weight, 4.5% of overweight, and 8% of
all obese women (≥ 30 kg/m2). Women who were diagnosed with GDM had significantly
higher odds (OR=2.12 95% CI: 1.73, 2.59) of having a baby with any type of CHD. Because
some women who developed GDM also might have had undiagnosed pregestational
diabetes, we performed sensitivity analyses excluding all women who developed GDM.
When women who developed GDM were excluded from the analytic population, the
association between maternal BMI and infant CHD was attenuated but remained significant
for the combined obesity categories (BMI ≥ 30 kg/m2) in the fully adjusted model: OR=1.18
(95%CI: 1.02–1.36) (data not shown). The association was in the same direction but was no
longer significant for overweight women: OR= 1.09 (95% CI: 0.95 – 1.25).

Author Manuscript

Regarding specific categories and types of CHD, the combined obesity group (BMI ≥ 30
kg/m2) had significantly increased odds for conotruncal defects (OR=1.33 95% CI: 1.03–
1.72), ventricular septal defects (OR=1.38 95% CI: 1.06–1.79), and atrial septal defects
(OR=1.22 95% CI: 1.04–1.43) (Table 3). There was no association between underweight or
overweight status for any specific type of CHD in either crude or adjusted models.
To determine whether the association between pre-pregnancy BMI and CHD persisted after
adjusting for glucose concentration later in pregnancy, we performed a sub-analysis
restricted to the site that reported the results of 1-hour oral glucose tolerance test (OGTT) for
more than 85% of women. This site had fewer women with missing BMI than the overall
study population, and CHD incidence at this site was 0.92% (47 defects), which was similar
to the 1.15% rate of CHD at sites that did not report OGTT values. We found after we
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adjusted for OGTT as a linear predictor, there was a 6% increased odds of CHD with one
unit increase in maternal BMI (adjusted OR=1.06, 95% CI 1.02 – 1.10) (Table 4). Among
all women at the site with OGTT results (n=5131), obese women (BMI ≥ 30 kg/m2) had an
OR for giving birth to an infant with any type of CHD of 1.96 (95% CI: 1.01, 3.80) (P=.045)
in the crude model and 2.38 (95% CI: 1.02, 3.76) (P=.023) after adjusting for age and OGTT
level. Moreover, the test for trend between increasing BMI and OR for congenital heart
defects remained significant (P=.015) after adjusting for OGTT levels.

Discussion

Author Manuscript

In this large U.S. cohort study, obese and overweight women were more likely than normal
weight women to deliver an infant with any CHD and among obese women, conotruncal,
ventricular septal or atrial septal defects in particular. Increasing maternal BMI had a “doseresponse” effect on CHD risk. Obesity remained a significant risk factor for CHD after
adjusting for glycemic status as measured by oral glucose tolerance test (OGTT).
Women with BMIs above the normal range are more likely to have pre-gestational diabetes
mellitus (DM), and diabetes is an established teratogen.18 Therefore, DM has been put forth
as a possible explanation for the observed increased CHD risk in obese mothers.19 However,
several studies have found the association persisted even after diabetic women were
excluded.2, 4, 6, 8 One possible explanation might be obese and overweight women are more
likely to have higher glucose concentrations that don’t meet the threshold for a diagnosis of
diabetes. 6, 7 No study to date has been able to test this hypothesis. We used OGTT tests as a
method of identifying possible glucose abnormalities during organogenesis. Even after
adjusting for glucose status, increasing BMI was associated with increasing risk of CHD,
and obese women still had higher risk of CHD.

Author Manuscript
Author Manuscript

The fact that maternal obesity was associated with risk of CHD even after taking abnormal
glucose metabolism (albeit evaluated later in pregnancy) into account suggests that
abnormalities in glucose metabolism do not fully explain the increased risk for CHD found
in obese women. Furthermore, obesity remained a significant risk factor for CHD after we
excluded all subjects with GDM (or undiagnosed pregestational diabetes), providing
additional support for the hypothesis that other factors contribute to the increased risk for
CHD in obese women. Obesity is associated with a wide range of metabolic abnormalities,
but little is known about their potential teratogenicity. Our results raise important questions
for future investigation. It has been hypothesized mothers with high pre-pregnancy BMI
may be at higher risk of giving birth to an infant with CHD because obese women may be
more likely to be dieting when they conceive;19 may have reduced folate levels;20 or may
have more-difficult-to-read ultrasound scans, resulting in fewer terminations of pregnancy
for fetal anomaly and therefore increased prevalence at birth.1, 7
Most studies have found that obesity was a risk factor for CHD, with similar effect sizes to
our study. 2, 4–7 The data are much less consistent, however, regarding the risk associated
with being overweight. Two prior case-control studies 2, 3 and two studies using birth
certificate data with inherent limitations5, 6 did not find overweight to be associated with
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CHD while other studies did, 1, 4, 8, 9 including a meta-analysis.7 Our study found
overweight status had a modest effect on CHD risk after accounting for other factors.

Author Manuscript

We also examined the relationship between specific types of CHD and prepregnancy BMI
and found that obese women were at an increased risk of having a neonate with conotruncal,
ventricular septal, and atrial septal defects. Our findings are consistent with prior studies that
found an association between obesity or morbid obesity and atrial and ventricular septal
defects.2, 4, 6, 7, 19 Although our numbers of specific defects were small, our finding that
overweight women were not at risk for giving birth to an infant with atrial or ventricular
septal defects is similar to prior reports.4, 6, 7 Results have been more mixed for conotruncal
defects. One study found an increased risk in obese mothers for conotruncal defects in
general.4 In contrast, several studies have found no association between prepregnancy BMI
for obese or overweight mothers and conotruncal defects in general5, 21, 22 or tetralogy of
Fallot specifically.2, 7, 21, 22

Author Manuscript

Some limitations of our study should be noted. BMI data were not available on all women.
However, CHD prevalence was somewhat higher in women with missing BMI data (1.68%)
than those in the analytic population (1.15%). We did not have data on potential teratogens
such as drugs, although they account for a small percentage of CHD. Cases not identified in
the nursery or cases terminated prenatally were not available for study. Many cases of CHD,
particularly atrial septal defects, ventricular septal defects, and Coarctation of aorta, may not
be diagnosed before discharge after birth, and we did not have full clinical data on infants
outside of ICD-9 discharge codes. Finally we were unable to account for any
misclassification of ICD-9 coding, despite the fact classification for congenital heart disease
has been shown to be inaccurate for certain types of defects, particularly tetralogy of Fallot,
where the sensitivity was 83% based on ICD-9 reports.23
A major strength of our study was the ability to examine the role of potentially impaired
glucose tolerance. Our study also had a large sample size, comprehensive maternal and
infant demographic and delivery characteristics, and reliable, uniform data collection from
medical charts. Because data were gathered prospectively from the medical records, several
types of measurement error and bias, particularly recall bias, were greatly minimized.

Author Manuscript

Our findings have important public health implications considering that approximately twothirds of American women 20–39 are overweight or obese according to the 2009–2010
National Health and Nutrition Examination Survey (NHANES) and are at greater risk of
giving birth to a child with CHD.24 A simulation conducted by Honein et al. demonstrated
that pre-pregnancy obesity may contribute to 2850 (95% CI: 1035–5065) CHD cases each
year in the U.S. Worldwide, the burden of overweight and obesity is increasing, particularly
in Latin America and the Caribbean, where 23% of women 20–29 are overweight and 11%
are obese.25

Conclusion
In summary, women who were obese when they conceived were at increased risk of having
an infant with a congenital heart defect. Abnormalities in glucose metabolism likely did not
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completely explain the increased risk in obese women. Other obesity-related factors should
be investigated as potential teratogens. Women should be counseled prior to conception that
obesity increases the risk for CHD and that weight reduction may decrease their risk.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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352 (25.4)
255 (18.4)
58 (4.2)
313 (22.6)

Overweight
25–<30 kg/m2

Obese
30–<40 kg/m2

Morbidly obese
40+ kg/m2

All obese
30+ kg/m2

569 (44.2)
6 (0.47)

Public/self-pay

Other
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27.11 (5.91)

305 (22.0)
34 (2.5)
42 (3.1)
27.43 (6.23)

Hispanic

Asian/Pacific Islander

Multi-racial/Other

Maternal age (years)

46889 (38.9)
35721 (29.7)
37817 (31.4)

0

1

2+

Parity, n (%)

2985 (2.6)

330 (23.8)

Black

443 (31.9)

404 (29.1)

541 (39.0)

3527 (3.0)

23294 (19.3)

24158 (20.1)

635 (45.8)

62083 (51.6)

139 (0.13)

42395 (38.4)

67973 (61.5)

23550 (19.6)

4087 (3.4)

19463 (16.2)

28519 (23.7)

62162 (51.7)

6196 (5.2)

25.53 (6.21)

No CHD (n=120427)

White

Race, n (%)

713 (55.4)

Private

Insurance, n (%)

651 (47.0)

72 (5.2)

26.30 (6.88)

Normal weight
18.5–<25 kg/m2

Underweight
<18.5 kg/m2

BMI categories, n (%)

BMI (kg/m2)

CHD (n=1388)

0.878

0.048

<0.001

<0.001

0.007

<0.001

p-value

Baseline characteristics of the Consortium on Safe Labor (CSL) study population women by congenital heart disease (CHD) status in offspring*
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Table 1
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1282 (92.4)
106 (7.6)

Yes

58 (4.2)

1330 (95.8)

32 (2.3)

No/unknown

Gestational diabetes, n (%)

Yes

No/unknown

History of depression, n (%)

Yes

No/unknown

1356 (97.7)

114 (8.2)

Yes

Alcohol during pregnancy, n (%)

1274 (91.8)

No/unknown

4528 (3.8)

115899 (96.2)

5445 (4.5)

114982 (95.5)

2215 (1.8)

118212 (98.1)

7963 (6.6)

112464 (93.4)

data presented are mean and standard deviation or N(%) when indicated

*

Author Manuscript

Smoking during pregnancy, n (%)

<0.001

0.541

0.199

0.017

p-value
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No CHD (n=120427)
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CHD (n=1388)
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23863

4145

19718

28871

62813

6268

313

58

255

352

651

72

Cases (n)

1.27 (1.11, 1.45)

1.36 (1.03–1.78)

1.25 (1.08–1.45)

1.18 (1.03–1.34)

1.00 (ref)

1.11 (0.87–1.42)

0.001

0.028

0.003

0.014

n/a

0.405

p-value for trend test=<.001

P value

1.26 (1.09–1.44)

1.34 (1.02–1.76)

1.24 (1.07–1.44)

1.15 (1.01–1.32)

1.00 (ref)

1.08 (0.85–1.38)

0.001

0.036

0.005

0.033

n/a

0.529

p-value for trend test=<.001

OR (95% CI)

OR (95%CI)

P value

Multivariable *

Crude

adjusted for site, age, race, insurance, maternal smoking

*

30+kg/m2

All Obese

40+kg/m2

Morbidly Obese

30–<40 kg/m2

Obese

25–<30 kg/m2

Overweight

18.5–<25 kg/m2

Normal Weight

<18.5kg/m2

Underweight

Total (n)

Odds ratios (OR) and 95% confidence intervals (CI) for congenital heart defects by categories of body mass index (BMI) among 121815 pregnancies in
the Consortium on Safe Labor

Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript
1.00 (ref)

1.35 (1.03–1.77)

1.18 (0.92–1.51)

1.21 (0.70–2.10)

N=

30+kg/m2

1.33 (1.03–1.72)

All Obese (n=23863)

40+kg/m2

Morbidly Obese (n=4145)

30–<40 kg/m2

Obese (n=19718)

25–<30 kg/m2

Overweight (n=28871)

18.5–<25 kg/m2

399

91

14

77

101

187

20

Sample sizes (n<50) too small for all other CHD types

**

adjusted for site, age, race, insurance, maternal smoking

*

1.04 (0.66–1.67)

Normal Weight (n=62813)

<18.5kg/m2

Underweight (n=6268)

p-value for trend test: 0.050

0.031

0.492

0.030

0.186

n/a

0.842

1.38 (1.06–1.79)

1.36 (0.79–2.34)

1.39 (1.05–1.83)

1.15 (0.89–1.49)

1.00 (ref)

0.99 (0.60–1.64)

360

85

14

71

89

169

17

0.016

0.272

0.021

0.286

n/a

0.974

P value

p-value for trend test: 0.029

Total Cases

OR* (95% CI)

P value

OR* (95% CI)
Total Cases

Ventricular Septal
p-value for trend test: 0.029

Conotruncal
p-value for trend test: 0.050
Total N Cases

1.22 (1.04–1.43)

1.37 (1.00–1.86)

1.19 (1.01–1.42)

1.12 (0.96–1.30)

1.00 (ref)

0.99 (0.74–1.32)

1060

237

46

191

267

505

51

p-value for trend test: 0.021

OR* (95% CI)

Atrial Septal
p-value for trend test: 0.021

0.014

0.048

0.042

0.145

n/a

0.929

P value

Odds ratios (OR)* and 95% confidence intervals (CI) for the effect of pre-pregnancy body mass index (BMI) on risk of types of congenital heart defects**
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30+

All Obese

40+

1426

311

20

8

12

10

16

Cases (n)

1.96 (1.01–3.80)

3.65 (1.55- 8.58)

1.50 (0.71–3.19)

1.10 (0.50–2.42)

1.00 (ref)

0.0451

0.0030

0.2884

0.8219

n/a

Oral glucose tolerance test

**

1.95 (1.02–3.76)

3.63 (1.55- 8.51)

1.50 (0.71–3.16)

1.09 (0.49–2.42)

1.00 (ref)

OR (95% CI)

OR (95% CI)

P value

Age-adjusted

Crude

Underweight category had an insufficient number of cases (n)=1.

*

1115

1272

2226

Morbidly Obese

30–39.9

Obese

25–29.9

Overweight

18.5–24.9

Normal Weight

BMI *:

Total (n)

0.0445

0.0030

0.2877

0.8261

n/a

P value

2.38 (1.12–5.05)

3.63 (1.33- 9.91)

2.04 (0.90–4.62)

0.83 (0.33–2.05)

1.00 (ref)

OR (95% CI)

Adjusted for age and OGTT **

0.023

0.021

0.088

0.686

n/a

P value

Odds of congenital heart disease by pre-pregnancy BMI category at site where OGTT results known (n=5131).
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